University Hospital and Faculty of Medicine Eberhard Karls University Tübingen

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC	PDAC	Recruiting	Phase 1 / Phase 2	2026-06-08		NCT07145450

Clinical trials